Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIsulfiram REsponse as add-on to ChemoTherapy in recurrent Glioblastoma
2016-000167-16Phase 2Terminated
- Sponsor
- Sahlgrenska University Hospital
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of disulfiram in glioblastoma (GBM) (2 arms), sponsored by Sahlgrenska University Hospital. Primary endpoint: Survival at 6 months. Started Mar 2016; status: terminated.
02
Drugs
disulfiram
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on 2016-000167-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000167-16.